Intraoperative Radiation Therapy Market by Technology (Electron IORT, Brachytherapy), Products & Services (Accelerators, Treatment Planning system, Applicators, Afterloaders, Accessories), Application (Breast, Brain, Lung Cancer) - Global Forecasts to 2025
The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period. The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players. However, the complex nature of technology coupled with a shortage of trained personnel and preference of conventional radiotherapy over IORT by physicians owing to reimbursement coverage are the major factors that are expected to restrain the growth of this market.
“The system/accelerators segment is expected to account for the largest market share during the forecast period.”
Based on product type, the intraoperative radiation therapy market products market is segmented into system/accelerators, treatment planning systems, applicators & afterloaders, and accessories. The systems/accelerators segment is expected to account for the largest share of the IORT products market in 2019. The large share of this segment can be attributed to the low cost of accelerators as compared to advanced radiosurgery products, growing applications of IORT products in cancer treatment, and the development of technologically advanced mobile systems/accelerators.
“The breast cancer segment is expected to hold the largest share of the intraoperative radiation therapy market, by application, during the forecast period.”
Based on application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head and neck cancer, colorectal cancer, endometrial and cervical cancer, lung cancer, and other cancers. The breast cancer segment is expected to account for the largest share of this market in 2019. The large share of this segment can be attributed to a high prevalence of breast cancer, coupled with advantages offered by IORT such as the reduced amount of irradiation, shorter treatment time, and lesser clinical risks.
“Europe to account for the second-largest share of the global market in 2019.”
The intraoperative radiation therapy market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and Middle East and Africa. Europe is expected to account for the second-largest share of the global intraoperative radiation therapy market in 2019. The growing incidence of cancer, supportive government initiatives, and the implementation of intraoperative radiation therapy market training programs & conferences/symposiums are the major factors propelling the demand for intraoperative radiation therapy market products in Europe. Furthermore, several key market players are focusing on enhancing their intraoperative radiation therapy market products to improve the quality of patient care across Europe.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
This report studies the IORT market based on product and service, technology, application, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
“The system/accelerators segment is expected to account for the largest market share during the forecast period.”
Based on product type, the intraoperative radiation therapy market products market is segmented into system/accelerators, treatment planning systems, applicators & afterloaders, and accessories. The systems/accelerators segment is expected to account for the largest share of the IORT products market in 2019. The large share of this segment can be attributed to the low cost of accelerators as compared to advanced radiosurgery products, growing applications of IORT products in cancer treatment, and the development of technologically advanced mobile systems/accelerators.
“The breast cancer segment is expected to hold the largest share of the intraoperative radiation therapy market, by application, during the forecast period.”
Based on application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head and neck cancer, colorectal cancer, endometrial and cervical cancer, lung cancer, and other cancers. The breast cancer segment is expected to account for the largest share of this market in 2019. The large share of this segment can be attributed to a high prevalence of breast cancer, coupled with advantages offered by IORT such as the reduced amount of irradiation, shorter treatment time, and lesser clinical risks.
“Europe to account for the second-largest share of the global market in 2019.”
The intraoperative radiation therapy market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and Middle East and Africa. Europe is expected to account for the second-largest share of the global intraoperative radiation therapy market in 2019. The growing incidence of cancer, supportive government initiatives, and the implementation of intraoperative radiation therapy market training programs & conferences/symposiums are the major factors propelling the demand for intraoperative radiation therapy market products in Europe. Furthermore, several key market players are focusing on enhancing their intraoperative radiation therapy market products to improve the quality of patient care across Europe.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–45%, Tier 2–34%, and Tier 3– 21%
- By Designation: C-level–47%, Director-level–33%, and Others–20%
- By Region: North America–35%, Europe–32%, Asia Pacific–25%, Latin America–6%, and the Middle East & Africa–2%
Research Coverage
This report studies the IORT market based on product and service, technology, application, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the Intraoperative radiation therapy market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the Intraoperative radiation therapy market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the Intraoperative radiation therapy market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: INTRAOPERATIVE RADIATION THERAPY MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: INTRAOPERATIVE RADIATION THERAPY MARKET
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 6 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 7 INTRAOPERATIVE RADIATION THERAPY MARKET SHARE, BY TECHNOLOGY, 2020 VS. 2025
FIGURE 8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE INTRAOPERATIVE RADIATION THERAPY MARKET
4 PREMIUM INSIGHTS
4.1 INTRAOPERATIVE RADIATION THERAPY MARKET OVERVIEW
FIGURE 10 GROWING PREVALENCE OF CANCER IS DRIVING THE GROWTH OF THE INTRAOPERATIVE RADIATION THERAPY MARKET
4.2 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 IORT PRODUCTS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
4.3 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 12 SYSTEMS & ACCELERATORS SEGMENT WILL CONTINUE TO DOMINATE THE NORTH AMERICAN MARKET IN 2025
4.4 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
FIGURE 13 ELECTRON IORT SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE APAC INTRAOPERATIVE RADIATION THERAPY MARKET
4.5 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION & COUNTRY (2019)
FIGURE 14 BREAST CANCER SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN INTRAOPERATIVE RADIATION THERAPY MARKET IN 2019
4.6 INTRAOPERATIVE RADIATION THERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 15 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 INTRAOPERATIVE RADIATION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing global prevalence of cancer
5.2.1.2 Improving reimbursement scenario
TABLE 1 NATIONAL AVERAGE MEDICARE REIMBURSEMENT CPT CODES, 2019
5.2.1.3 Procedural advantages over EBRT
5.2.1.4 Technological advancements
5.2.2 RESTRAINTS
5.2.2.1 Dearth of trained personnel
5.2.2.2 Strong market positioning of alternative therapies
TABLE 2 ALTERNATIVES TO IORT PROCEDURES
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies offer high growth potential
5.2.3.2 Growing applications of IORT
5.2.4 CHALLENGES
5.2.4.1 Risk of radiation exposure
5.3 IMPACT OF COVID-19 ON THE INTRAOPERATIVE RADIATION THERAPY MARKET
5.4 GLOBAL REGULATORY SCENARIO
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 3 US: MEDICAL DEVICE CLASSIFICATION
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.1.2 Canada
TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 17 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.4.2 EUROPE
FIGURE 18 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.4.3 ASIA PACIFIC
5.4.3.1 Japan
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.4.3.2 China
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.4.3.3 India
5.5 VALUE CHAIN ANALYSIS: GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING THE MANUFACTURING PHASE
5.6 ECOSYSTEM COVERAGE: GLOBAL RADIOTHERAPY MARKET
6 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
6.2 IORT PRODUCTS
TABLE 9 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 10 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.1 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TECHNOLOGY
TABLE 11 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
6.2.2 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY APPLICATION
TABLE 12 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
6.2.3 SYSTEMS & ACCELERATORS
6.2.3.1 Affordability of systems & accelerators is supporting their adoption
TABLE 13 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY REGION, 2018–2025 (USD MILLION)
6.2.3.2 Intraoperative radiation therapy market for systems & accelerators, by technology
TABLE 14 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY TECHNOLOGY, 2018–2025 (USD MILLION)
6.2.3.3 Intraoperative radiation therapy market for systems & accelerators, by application
TABLE 15 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY APPLICATION, 2018–2025 (USD MILLION)
6.2.4 APPLICATORS & AFTERLOADERS
6.2.4.1 Growing approvals of applicators & afterloaders for the treatment of different cancer types is supporting the growth of this segment
TABLE 16 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY REGION, 2018–2025 (USD MILLION)
6.2.4.2 Intraoperative radiation therapy market for applicators & afterloaders, by technology
TABLE 17 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY TECHNOLOGY, 2018–2025 (USD MILLION)
6.2.4.3 Intraoperative radiation therapy market for applicators & afterloaders, by application
TABLE 18 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY APPLICATION, 2018–2025 (USD MILLION)
6.2.5 TREATMENT PLANNING SYSTEMS
6.2.5.1 Technological advancements & growing regulatory approvals are supporting market growth
TABLE 19 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY REGION, 2018–2025 (USD MILLION)
6.2.5.2 Intraoperative radiation therapy market for treatment planning systems, by technology
TABLE 20 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY TECHNOLOGY, 2018–2025 (USD MILLION)
6.2.5.3 Intraoperative radiation therapy market for treatment planning systems, by application
TABLE 21 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY APPLICATION, 2018–2025 (USD MILLION)
6.2.6 ACCESSORIES
6.2.6.1 Growing number of IORT procedures to drive the adoption of IORT accessories
TABLE 22 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES, BY REGION, 2018–2025 (USD MILLION)
6.2.6.2 Intraoperative radiation therapy market for accessories, by technology
TABLE 23 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES, BY TECHNOLOGY, 2018–2025 (USD MILLION)
6.2.6.3 Intraoperative radiation therapy market for accessories, by application
TABLE 24 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES, BY APPLICATION, 2018–2025 (USD MILLION)
6.3 IORT SERVICES
6.3.1 NEED FOR FREQUENT SOFTWARE UPGRADES TO DRIVE MARKET GROWTH
TABLE 25 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY REGION, 2018–2025 (USD MILLION)
6.3.2 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY TECHNOLOGY
TABLE 26 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY TECHNOLOGY, 2018–2025 (USD MILLION)
6.3.3 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY APPLICATION
TABLE 27 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY APPLICATION, 2018–2025 (USD MILLION)
7 INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 28 INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
7.2 ELECTRON IORT
7.2.1 MINIMAL TREATMENT TIME OF THIS PROCEDURE HAS INCREASED ITS ADOPTION IN THE MARKET
TABLE 29 PROMISING CLINICAL TRIALS FOR ELECTRON IORT
TABLE 30 ELECTRON IORT MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 INTRAOPERATIVE BRACHYTHERAPY
7.3.1 LOWER COST THAN IOERT & BETTER DOSIMETRIC DISTRIBUTION ARE THE KEY FACTORS SUPPORTING MARKET GROWTH
TABLE 31 INTRAOPERATIVE BRACHYTHERAPY MARKET, BY REGION, 2018–2025 (USD MILLION)
8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 32 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.2 BREAST CANCER
8.2.1 GROWING NUMBER OF BREAST CANCER CASES ACROSS THE GLOBE IS FUELING THE ADOPTION OF IORT
TABLE 33 INTRAOPERATIVE RADIATION THERAPY MARKET FOR BREAST CANCER, BY REGION, 2018–2025 (USD MILLION)
8.3 BRAIN TUMOR
8.3.1 GROWING NUMBER OF BRAIN TUMOR CASES TO DRIVE MARKET GROWTH
TABLE 34 INTRAOPERATIVE RADIATION THERAPY MARKET FOR BRAIN TUMOR, BY REGION, 2018–2025 (USD MILLION)
8.4 GASTROINTESTINAL CANCER
8.4.1 IORT OFFERS A SUITABLE ALTERNATIVE FOR GASTROINTESTINAL CANCER TREATMENT AS OPPOSED TO SURGERY OR CONVENTIONAL RADIATION
TABLE 35 INTRAOPERATIVE RADIATION THERAPY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2018–2025 (USD MILLION)
8.5 HEAD & NECK CANCER
8.5.1 IORT IS HIGHLY EFFICIENT IN THE TREATMENT OF HEAD & NECK CANCER AS IT OFFERS BETTER TUMOR CONTROL
TABLE 36 INTRAOPERATIVE RADIATION THERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2018–2025 (USD MILLION)
8.6 COLORECTAL CANCER
8.6.1 IORT IS PROVEN EFFECTIVE FOR ADVANCED LOCAL AND RECURRENT COLORECTAL CANCER TREATMENT IN COMBINATION WITH PREOPERATIVE EBRT
TABLE 37 INTRAOPERATIVE RADIATION THERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2018–2025 (USD MILLION)
8.7 ENDOMETRIAL & CERVICAL CANCER
8.7.1 IORT IN COMBINATION WITH RADICAL RESECTION PROCEDURES IS A CURATIVE OPTION FOR PATIENTS WITH RECURRENT ENDOMETRIAL CANCER
TABLE 38 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ENDOMETRIAL & CERVICAL CANCER, BY REGION, 2018–2025 (USD MILLION)
8.8 LUNG CANCER
8.8.1 ALTERNATIVE TREATMENT OPTIONS FOR LUNG CANCER IS EXPECTED TO HAMPER THE GROWTH OF THIS SEGMENT
TABLE 39 INTRAOPERATIVE RADIATION THERAPY MARKET FOR LUNG CANCER, BY REGION, 2018–2025 (USD MILLION)
8.9 OTHER CANCERS
TABLE 40 INTRAOPERATIVE RADIATION THERAPY MARKET FOR OTHER CANCERS, BY REGION, 2018–2025 (USD MILLION)
9 INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION
9.1 INTRODUCTION
TABLE 41 INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2018–2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET SNAPSHOT
TABLE 42 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 44 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 45 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
9.2.1 US
9.2.1.1 Higher adoption rate of innovative technologies to support market growth in the US
TABLE 46 US: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Surge in the incidence of cancer and favorable government guidelines to support the market growth
TABLE 47 CANADA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.3 EUROPE
TABLE 48 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 50 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 51 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Growing awareness about advanced cancer treatment is expected to fuel the adoption of IORT products in Germany
TABLE 52 GERMANY: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.3.2 UK
9.3.2.1 Initiatives by public & private organizations to increase awareness about IORT
TABLE 53 UK: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Preference for conventional radiotherapy is restraining the growth of the IORT market in France
TABLE 54 FRANCE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.3.4 SPAIN
9.3.4.1 Growing geriatric population to support market growth
TABLE 55 SPAIN: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Rising awareness activities to support market growth
TABLE 56 ITALY: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 57 REST OF EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 21 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET SNAPSHOT
TABLE 58 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 59 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 60 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 61 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Increasing patient pool and government initiatives for healthcare development are fueling the market growth
TABLE 62 CHINA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Presence of universal healthcare reimbursement scenario and rising breast cancer cases—key factors driving market growth
TABLE 63 JAPAN: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Government initiatives to improve cancer treatment to drive market growth in India
TABLE 64 INDIA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.4.4 SOUTH KOREA
9.4.4.1 Rising R&D and promising clinical trials in the country to positively impact market growth
TABLE 65 SOUTH KOREA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.4.5 AUSTRALIA
9.4.5.1 Rising research investments and awareness campaigns are the key factors supporting market growth
TABLE 66 AUSTRALIA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC
TABLE 67 REST OF ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.5 LATIN AMERICA
TABLE 68 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 69 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 70 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 71 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Brazil is a key market in Latin America owing to the modernization of healthcare facilities
TABLE 72 BRAZIL: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Availability of advanced care and increasing awareness programs are fueling market growth in Mexico
TABLE 73 MEXICO: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 74 REST OF LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA
TABLE 75 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 76 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 77 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
FIGURE 22 KEY DEVELOPMENTS IN THE INTRAOPERATIVE RADIATION THERAPY MARKET FROM 2017 TO 2020
10.2 MARKET SHARE ANALYSIS
FIGURE 23 INTRAOPERATIVE RADIATION THERAPY MARKET SHARE, BY KEY PLAYER, 2019
10.3 KEY MARKET DEVELOPMENTS
10.3.1 PRODUCT LAUNCHES & APPROVALS
10.3.2 ACQUISITIONS
10.3.3 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
10.3.4 EXPANSIONS
11 COMPANY EVOLUTION MATRIX AND COMPANY PROFILES
11.1 COMPETITIVE EVALUATION MATRIX AND METHODOLOGY
11.1.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2019)
11.1.2 STARS
11.1.3 EMERGING LEADERS
11.1.4 EMERGING COMPANIES
11.1.5 PERVASIVE
FIGURE 24 COMPETITIVE LEADERSHIP MAPPING: OVERALL MARKET (2019)
FIGURE 25 COMPETITIVE LEADERSHIP MAPPING: EMERGING PLAYERS (2019)
11.2 COMPANY PROFILES
(Business overview, Products offered, Recent developments, MNM view)*
11.2.1 ZEISS GROUP
FIGURE 26 ZEISS GROUP: COMPANY SNAPSHOT (2019)
11.2.2 ICAD, INC.
FIGURE 27 ICAD, INC.: COMPANY SNAPSHOT (2019)
11.2.3 ECKERT & ZIEGLER
FIGURE 28 ECKERT & ZIEGLER: COMPANY SNAPSHOT (2019)
11.2.4 ARIANE MEDICAL SYSTEMS LTD.
11.2.5 BECTON, DICKINSON AND COMPANY
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
11.2.6 ELEKTA AB
FIGURE 30 ELEKTA AB: COMPANY SNAPSHOT (2019)
11.2.7 GMV INNOVATING SOLUTIONS
11.2.8 INTRAOP MEDICAL, INC.
11.2.9 ISOAID, LLC
11.2.10 ISORAY, INC.
FIGURE 31 ISORAY, INC.: COMPANY SNAPSHOT (2019)
11.2.11 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
11.2.12 SEEDOS LTD.
11.2.13 SENSUS HEALTHCARE, INC.
FIGURE 32 SENSUS HEALTHCARE, INC.: COMPANY SNAPSHOT (2019)
11.2.14 S.I.T. SORDINA IORT TECHNOLOGIES S.P.A.
11.2.15 VARIAN MEDICAL SYSTEMS, INC.
FIGURE 33 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2019)
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
11.2.16 OTHER COMPANIES
11.2.16.1 Salutaris Medical Devices
11.2.16.2 Brainlab AG
11.2.16.3 RaySearch Laboratories
11.2.16.4 REMEDI Co., Ltd.
11.2.16.5 Merit Medical Systems
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: INTRAOPERATIVE RADIATION THERAPY MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: INTRAOPERATIVE RADIATION THERAPY MARKET
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 6 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 7 INTRAOPERATIVE RADIATION THERAPY MARKET SHARE, BY TECHNOLOGY, 2020 VS. 2025
FIGURE 8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE INTRAOPERATIVE RADIATION THERAPY MARKET
4 PREMIUM INSIGHTS
4.1 INTRAOPERATIVE RADIATION THERAPY MARKET OVERVIEW
FIGURE 10 GROWING PREVALENCE OF CANCER IS DRIVING THE GROWTH OF THE INTRAOPERATIVE RADIATION THERAPY MARKET
4.2 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 IORT PRODUCTS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
4.3 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 12 SYSTEMS & ACCELERATORS SEGMENT WILL CONTINUE TO DOMINATE THE NORTH AMERICAN MARKET IN 2025
4.4 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
FIGURE 13 ELECTRON IORT SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE APAC INTRAOPERATIVE RADIATION THERAPY MARKET
4.5 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION & COUNTRY (2019)
FIGURE 14 BREAST CANCER SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN INTRAOPERATIVE RADIATION THERAPY MARKET IN 2019
4.6 INTRAOPERATIVE RADIATION THERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 15 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 INTRAOPERATIVE RADIATION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing global prevalence of cancer
5.2.1.2 Improving reimbursement scenario
TABLE 1 NATIONAL AVERAGE MEDICARE REIMBURSEMENT CPT CODES, 2019
5.2.1.3 Procedural advantages over EBRT
5.2.1.4 Technological advancements
5.2.2 RESTRAINTS
5.2.2.1 Dearth of trained personnel
5.2.2.2 Strong market positioning of alternative therapies
TABLE 2 ALTERNATIVES TO IORT PROCEDURES
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies offer high growth potential
5.2.3.2 Growing applications of IORT
5.2.4 CHALLENGES
5.2.4.1 Risk of radiation exposure
5.3 IMPACT OF COVID-19 ON THE INTRAOPERATIVE RADIATION THERAPY MARKET
5.4 GLOBAL REGULATORY SCENARIO
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 3 US: MEDICAL DEVICE CLASSIFICATION
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.1.2 Canada
TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 17 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.4.2 EUROPE
FIGURE 18 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.4.3 ASIA PACIFIC
5.4.3.1 Japan
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.4.3.2 China
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.4.3.3 India
5.5 VALUE CHAIN ANALYSIS: GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING THE MANUFACTURING PHASE
5.6 ECOSYSTEM COVERAGE: GLOBAL RADIOTHERAPY MARKET
6 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
6.2 IORT PRODUCTS
TABLE 9 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 10 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.1 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TECHNOLOGY
TABLE 11 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
6.2.2 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY APPLICATION
TABLE 12 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
6.2.3 SYSTEMS & ACCELERATORS
6.2.3.1 Affordability of systems & accelerators is supporting their adoption
TABLE 13 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY REGION, 2018–2025 (USD MILLION)
6.2.3.2 Intraoperative radiation therapy market for systems & accelerators, by technology
TABLE 14 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY TECHNOLOGY, 2018–2025 (USD MILLION)
6.2.3.3 Intraoperative radiation therapy market for systems & accelerators, by application
TABLE 15 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY APPLICATION, 2018–2025 (USD MILLION)
6.2.4 APPLICATORS & AFTERLOADERS
6.2.4.1 Growing approvals of applicators & afterloaders for the treatment of different cancer types is supporting the growth of this segment
TABLE 16 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY REGION, 2018–2025 (USD MILLION)
6.2.4.2 Intraoperative radiation therapy market for applicators & afterloaders, by technology
TABLE 17 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY TECHNOLOGY, 2018–2025 (USD MILLION)
6.2.4.3 Intraoperative radiation therapy market for applicators & afterloaders, by application
TABLE 18 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY APPLICATION, 2018–2025 (USD MILLION)
6.2.5 TREATMENT PLANNING SYSTEMS
6.2.5.1 Technological advancements & growing regulatory approvals are supporting market growth
TABLE 19 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY REGION, 2018–2025 (USD MILLION)
6.2.5.2 Intraoperative radiation therapy market for treatment planning systems, by technology
TABLE 20 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY TECHNOLOGY, 2018–2025 (USD MILLION)
6.2.5.3 Intraoperative radiation therapy market for treatment planning systems, by application
TABLE 21 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY APPLICATION, 2018–2025 (USD MILLION)
6.2.6 ACCESSORIES
6.2.6.1 Growing number of IORT procedures to drive the adoption of IORT accessories
TABLE 22 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES, BY REGION, 2018–2025 (USD MILLION)
6.2.6.2 Intraoperative radiation therapy market for accessories, by technology
TABLE 23 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES, BY TECHNOLOGY, 2018–2025 (USD MILLION)
6.2.6.3 Intraoperative radiation therapy market for accessories, by application
TABLE 24 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES, BY APPLICATION, 2018–2025 (USD MILLION)
6.3 IORT SERVICES
6.3.1 NEED FOR FREQUENT SOFTWARE UPGRADES TO DRIVE MARKET GROWTH
TABLE 25 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY REGION, 2018–2025 (USD MILLION)
6.3.2 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY TECHNOLOGY
TABLE 26 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY TECHNOLOGY, 2018–2025 (USD MILLION)
6.3.3 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY APPLICATION
TABLE 27 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY APPLICATION, 2018–2025 (USD MILLION)
7 INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 28 INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
7.2 ELECTRON IORT
7.2.1 MINIMAL TREATMENT TIME OF THIS PROCEDURE HAS INCREASED ITS ADOPTION IN THE MARKET
TABLE 29 PROMISING CLINICAL TRIALS FOR ELECTRON IORT
TABLE 30 ELECTRON IORT MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 INTRAOPERATIVE BRACHYTHERAPY
7.3.1 LOWER COST THAN IOERT & BETTER DOSIMETRIC DISTRIBUTION ARE THE KEY FACTORS SUPPORTING MARKET GROWTH
TABLE 31 INTRAOPERATIVE BRACHYTHERAPY MARKET, BY REGION, 2018–2025 (USD MILLION)
8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 32 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.2 BREAST CANCER
8.2.1 GROWING NUMBER OF BREAST CANCER CASES ACROSS THE GLOBE IS FUELING THE ADOPTION OF IORT
TABLE 33 INTRAOPERATIVE RADIATION THERAPY MARKET FOR BREAST CANCER, BY REGION, 2018–2025 (USD MILLION)
8.3 BRAIN TUMOR
8.3.1 GROWING NUMBER OF BRAIN TUMOR CASES TO DRIVE MARKET GROWTH
TABLE 34 INTRAOPERATIVE RADIATION THERAPY MARKET FOR BRAIN TUMOR, BY REGION, 2018–2025 (USD MILLION)
8.4 GASTROINTESTINAL CANCER
8.4.1 IORT OFFERS A SUITABLE ALTERNATIVE FOR GASTROINTESTINAL CANCER TREATMENT AS OPPOSED TO SURGERY OR CONVENTIONAL RADIATION
TABLE 35 INTRAOPERATIVE RADIATION THERAPY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2018–2025 (USD MILLION)
8.5 HEAD & NECK CANCER
8.5.1 IORT IS HIGHLY EFFICIENT IN THE TREATMENT OF HEAD & NECK CANCER AS IT OFFERS BETTER TUMOR CONTROL
TABLE 36 INTRAOPERATIVE RADIATION THERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2018–2025 (USD MILLION)
8.6 COLORECTAL CANCER
8.6.1 IORT IS PROVEN EFFECTIVE FOR ADVANCED LOCAL AND RECURRENT COLORECTAL CANCER TREATMENT IN COMBINATION WITH PREOPERATIVE EBRT
TABLE 37 INTRAOPERATIVE RADIATION THERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2018–2025 (USD MILLION)
8.7 ENDOMETRIAL & CERVICAL CANCER
8.7.1 IORT IN COMBINATION WITH RADICAL RESECTION PROCEDURES IS A CURATIVE OPTION FOR PATIENTS WITH RECURRENT ENDOMETRIAL CANCER
TABLE 38 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ENDOMETRIAL & CERVICAL CANCER, BY REGION, 2018–2025 (USD MILLION)
8.8 LUNG CANCER
8.8.1 ALTERNATIVE TREATMENT OPTIONS FOR LUNG CANCER IS EXPECTED TO HAMPER THE GROWTH OF THIS SEGMENT
TABLE 39 INTRAOPERATIVE RADIATION THERAPY MARKET FOR LUNG CANCER, BY REGION, 2018–2025 (USD MILLION)
8.9 OTHER CANCERS
TABLE 40 INTRAOPERATIVE RADIATION THERAPY MARKET FOR OTHER CANCERS, BY REGION, 2018–2025 (USD MILLION)
9 INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION
9.1 INTRODUCTION
TABLE 41 INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2018–2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET SNAPSHOT
TABLE 42 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 44 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 45 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
9.2.1 US
9.2.1.1 Higher adoption rate of innovative technologies to support market growth in the US
TABLE 46 US: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Surge in the incidence of cancer and favorable government guidelines to support the market growth
TABLE 47 CANADA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.3 EUROPE
TABLE 48 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 50 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 51 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Growing awareness about advanced cancer treatment is expected to fuel the adoption of IORT products in Germany
TABLE 52 GERMANY: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.3.2 UK
9.3.2.1 Initiatives by public & private organizations to increase awareness about IORT
TABLE 53 UK: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Preference for conventional radiotherapy is restraining the growth of the IORT market in France
TABLE 54 FRANCE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.3.4 SPAIN
9.3.4.1 Growing geriatric population to support market growth
TABLE 55 SPAIN: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Rising awareness activities to support market growth
TABLE 56 ITALY: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 57 REST OF EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 21 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET SNAPSHOT
TABLE 58 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 59 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 60 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 61 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Increasing patient pool and government initiatives for healthcare development are fueling the market growth
TABLE 62 CHINA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Presence of universal healthcare reimbursement scenario and rising breast cancer cases—key factors driving market growth
TABLE 63 JAPAN: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Government initiatives to improve cancer treatment to drive market growth in India
TABLE 64 INDIA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.4.4 SOUTH KOREA
9.4.4.1 Rising R&D and promising clinical trials in the country to positively impact market growth
TABLE 65 SOUTH KOREA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.4.5 AUSTRALIA
9.4.5.1 Rising research investments and awareness campaigns are the key factors supporting market growth
TABLE 66 AUSTRALIA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC
TABLE 67 REST OF ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.5 LATIN AMERICA
TABLE 68 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 69 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 70 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 71 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Brazil is a key market in Latin America owing to the modernization of healthcare facilities
TABLE 72 BRAZIL: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Availability of advanced care and increasing awareness programs are fueling market growth in Mexico
TABLE 73 MEXICO: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 74 REST OF LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA
TABLE 75 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
TABLE 76 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 77 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
FIGURE 22 KEY DEVELOPMENTS IN THE INTRAOPERATIVE RADIATION THERAPY MARKET FROM 2017 TO 2020
10.2 MARKET SHARE ANALYSIS
FIGURE 23 INTRAOPERATIVE RADIATION THERAPY MARKET SHARE, BY KEY PLAYER, 2019
10.3 KEY MARKET DEVELOPMENTS
10.3.1 PRODUCT LAUNCHES & APPROVALS
10.3.2 ACQUISITIONS
10.3.3 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
10.3.4 EXPANSIONS
11 COMPANY EVOLUTION MATRIX AND COMPANY PROFILES
11.1 COMPETITIVE EVALUATION MATRIX AND METHODOLOGY
11.1.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2019)
11.1.2 STARS
11.1.3 EMERGING LEADERS
11.1.4 EMERGING COMPANIES
11.1.5 PERVASIVE
FIGURE 24 COMPETITIVE LEADERSHIP MAPPING: OVERALL MARKET (2019)
FIGURE 25 COMPETITIVE LEADERSHIP MAPPING: EMERGING PLAYERS (2019)
11.2 COMPANY PROFILES
(Business overview, Products offered, Recent developments, MNM view)*
11.2.1 ZEISS GROUP
FIGURE 26 ZEISS GROUP: COMPANY SNAPSHOT (2019)
11.2.2 ICAD, INC.
FIGURE 27 ICAD, INC.: COMPANY SNAPSHOT (2019)
11.2.3 ECKERT & ZIEGLER
FIGURE 28 ECKERT & ZIEGLER: COMPANY SNAPSHOT (2019)
11.2.4 ARIANE MEDICAL SYSTEMS LTD.
11.2.5 BECTON, DICKINSON AND COMPANY
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
11.2.6 ELEKTA AB
FIGURE 30 ELEKTA AB: COMPANY SNAPSHOT (2019)
11.2.7 GMV INNOVATING SOLUTIONS
11.2.8 INTRAOP MEDICAL, INC.
11.2.9 ISOAID, LLC
11.2.10 ISORAY, INC.
FIGURE 31 ISORAY, INC.: COMPANY SNAPSHOT (2019)
11.2.11 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
11.2.12 SEEDOS LTD.
11.2.13 SENSUS HEALTHCARE, INC.
FIGURE 32 SENSUS HEALTHCARE, INC.: COMPANY SNAPSHOT (2019)
11.2.14 S.I.T. SORDINA IORT TECHNOLOGIES S.P.A.
11.2.15 VARIAN MEDICAL SYSTEMS, INC.
FIGURE 33 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2019)
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
11.2.16 OTHER COMPANIES
11.2.16.1 Salutaris Medical Devices
11.2.16.2 Brainlab AG
11.2.16.3 RaySearch Laboratories
11.2.16.4 REMEDI Co., Ltd.
11.2.16.5 Merit Medical Systems
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
